Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

272.83 USD +0.07 (+0.03%)
Streaming Delayed Price Updated: 9:05 AM EDT, Sep 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Blog posts about Biogen, Inc.

< Previous 1 2 3 4 5 Next >
Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Post Earnings Coverage as Biogen Post 23% growth in EPS
[Accesswire] – LONDON, UK / ACCESSWIRE / July 22, 2016 / Active Wall St. announces its post-earnings coverage on Biogen Inc. (NASDAQ: BIIB ). The company announced its Q2 FY16 financial results before... 
Tags NASDAQ Finance Healthcare
From Jutia Group
Market Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen to Report Second Quarter 2016 Financial Results on July 21, 2016
[Business Wire] – Biogen Inc. today announced it will report second quarter 2016 financial results on Thursday, July 21, 2016, before the financial markets open. Read more on this. Biogen Inc. (BIIB) ,... 
Tags Stock Industry NASDAQ:BIIB
From Jutia Group
DHUnplugged #317: China – DENIED
China markets were once again denied the coveted inclusion by MSCI in a further setback to the markets. Brexit worries are preventing new market highs as trades are unwound ahead of the June 23rd vote... 
Tags Media Markets DH/Unplugged
From Disciplined Investor
Notable Analyst Calls: Sarepta Therapeutics (SRPT), Biogen Inc. (BIIB), Regulus Therapeutics (RGLS), Western Digital Corporation (WDC)
Sarepta Therapeutics, Inc. (SRPT) was raised to ‘Outperform’ from ‘Neutral’ and it was given $36 price target at Wedbush on ... View the full post at: Notable Analyst Calls: Sarepta Therapeutics... 
Tags Markets SRPT News
From Wall Street Pit
Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen’s Investigational Alzheimer’s Disease Treatment Aducanumab Accepted into European Medicines Agency’s PRIME Program
[Business Wire] – Today Biogen announced that aducanumab, its investigational treatment for early Alzheimer’s disease , was accepted into the European Medicines Agency’s PRIority MEdicines program.... 
Tags Business NASDAQ:BIIB Industry
From Jutia Group
Stock Update (NASDAQ:BIIB): SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Securities Fraud Violations by Certain Officers and Directors of Bioge
[Business Wire] – Levi & Korsinsky announces it has commenced an investigation of Biogen Inc. concerning possible violations of federal securities laws. Read more on this. Biogen Inc. (BIIB) ,... 
Tags Healthcare NASDAQ NASDAQ:BIIB
From Jutia Group
Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Announces Collaboration with University of Pennsylvania on Multiple Gene Therapy Programs
[Business Wire] – Biogen today announced a broad collaboration and alliance with the University of Pennsylvania to advance gene therapy and gene editing technologies. The expansive research and... 
Tags Healthcare NASDAQ Stock
From Jutia Group
Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen to spin off hemophilia drug business into a public company
[Reuters] – Drugmaker Biogen Inc said on Tuesday it intends to spin off its hemophilia drug business as an independent, publicly traded company in a tax-free transaction. Biogen said the new company... 
Tags Healthcare NASDAQ Technology
From Jutia Group
Market Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Appoints Michael Ehlers Executive Vice President, Research and Development
[Business Wire] – Biogen today announced the appointment of Michael Ehlers, M.D., Ph.D., as executive vice president, Research and Development. Read more on this. Biogen Inc. (BIIB) , currently valued... 
Tags Healthcare NASDAQ Stock
From Jutia Group
Market Update (NASDAQ:BIIB): Biogen to Present at the Goldman Sachs Alzheimer’s Symposium
[Business Wire] – Biogen Inc. announced today that it will present at the Goldman Sachs Alzheimer’s Symposium. The webcast will be live on Monday, April 11, 2016 at 12:20p.m. ET. To access the live... 
Tags NASDAQ Healthcare Industry
From Jutia Group
Market Update (NASDAQ:BIIB): Biogen 2015 Revenues Increase 11% to $10.8 Billion
[Business Wire] – Biogen Inc. today reported full year and fourth quarter 2015 results, including full year revenues of $10.8 billion, an 11% increase versus 2014. Full year 2015 Non-GAAP diluted... 
Tags NASDAQ Business NASDAQ:BIIB
From Jutia Group
Company Update (NASDAQ:BIIB): Biogen to Report Fourth Quarter and Year End 2015 Financial Results on January 27, 2016
[Business Wire] – Biogen Inc. today announced it will report fourth quarter and year end 2015 financial results on Wednesday, January 27, 2016, before the financial markets open. Read more on this.... 
Tags NASDAQ Healthcare Business
From Jutia Group
Stock Update (NASDAQ:BIIB): Biogen to Present at the 34th Annual J.P. Morgan Healthcare Conference
[Business Wire] – Biogen Inc. announced today that it will present at the 34th Annual J.P. Morgan Healthcare Conference. The webcast will be live on Monday, January 11, 2016 at 3:30 p.m. Read more on... 
Tags NASDAQ Healthcare Business
From Jutia Group
Cramer Bullish on Biogen (BIIB), Celgene (CELG) & Nvidia (NVDA)
Here’s what Jim Cramer had to say Friday evening about some of the stocks he will be watching next week: The Mad Money host is bullish on Geron Corporation (GERN), saying : “We have got Biogen (BIIB)... 
Tags Markets TopL News
From Wall Street Pit
Stock Update (NASDAQ:BIIB): Glancy Prongay & Murray LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Biogen Inc.
[Business Wire] – Glancy Prongay & Murray LLP reminds investors that a class action complaint has been filed on behalf of a class comprising investors of Biogen Inc. who purchased shares between... 
Tags Markets NASDAQ:BIIB Business
From Jutia Group
Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. Investors
[Business Wire] – Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors of Biogen, Inc. who purchased shares between January 29, 2015 and . . . →... 
Tags Healthcare NASDAQ Stock
From Jutia Group
Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Announces Departure of Tony Kingsley
[Business Wire] – Biogen today announced that Tony Kingsley, executive vice president, Global Commercial Operations, will leave the company and a search has been initiated for a permanent replacement.... 
Tags Healthcare NASDAQ Stock
From Jutia Group
Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Announces Webcast of Investor R&D Day
[Business Wire] – Biogen Inc. today announced that it will hold an Investor R&D Day with live webcast on Tuesday, November 3, 2015 at 10:00 a.m. ET. To access the live webcast, please . . . → Read... 
Tags Healthcare NASDAQ Markets
From Jutia Group
Market Update (NASDAQ:BIIB): Biogen and Sobi Receive Positive Opinion from CHMP for ELOCTA™ (rFVIIIFc) for the Treatment of Hemophilia A
[Business Wire] – Biogen and Swedish Orphan Biovitrum AB received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use for the marketing... 
Tags Healthcare NASDAQ Stock
From Jutia Group
Company Update (NASDAQ:BIIB): Biogen Named the Global Biotechnology Industry Leader on Dow Jones Sustainability World Index for Second Consecutive Year
[Business Wire] – Biogen has been named the biotechnology industry leader on the Dow Jones Sustainability World Index for the second year in a row, after becoming the first U.S.-based biotech company... 
Tags NASDAQ Stock Business
From Jutia Group
Market Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen, the ALS Association and Columbia University Medical Center Collaborate to Drive Understanding of Genetic Influence in ALS
[Business Wire] – Biogen , the ALS Association and Columbia University Medical Center today announced a new collaboration to better understand the differences and commonalities in the ALS disease... 
Tags Stock NASDAQ:BIIB Markets
From Jutia Group
Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of ALPROLIX for the Treatment of Hemophilia B
[Business Wire] – DALLAS–(BUSINESSWIRE)– New clinical data support the long-term safety and efficacy of ALPROLIX® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] in people with severe... 
Tags News Healthcare Markets
From Jutia Group
Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate® Published in Haemophilia
[Business Wire] – CAMBRIDGE, Mass. & STOCKHOLM–(BUSINESSWIRE)– Newly published clinical data demonstrate that people on extended-interval prophylaxis regimens with ELOCTATE® [Antihemophilic Factor... 
Tags News Healthcare World
From Jutia Group
Market Update: Biogen Idec Inc (NASDAQ:BIIB) – SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of F
[PR Newswire] – NEW YORK, Aug. 4, 2015 /PRNewswire/ — Levi & Korsinsky is investigating the Board of Directors of Biogen Inc. (“Biogen” or the “Company”) (NASDAQGS: BIIB) for possible violations of … .... 
Tags NASDAQ:BIIB Markets Stock
From Jutia Group
Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – BIIB INVESTORS: The Law Offices of Howard G. Smith Announces An Investigation On Behalf Of Biogen, Inc. Investors
[Business Wire] – Law Offices of Howard G. Smith announces an investigation on behalf of Biogen, Inc. investors, concerning the Company’s and its officers’ alleged violations of federal securities... 
Tags Business NASDAQ:BIIB Markets
From Jutia Group
Company Update: Biogen Idec Inc (NASDAQ:BIIB) – SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Biogen, Inc.
[PR Newswire] – NEW YORK, July 28, 2015 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Biogen,... 
Tags NASDAQ:BIIB Markets Stock
From Jutia Group
Notable Upgrades: Biogen (BIIB), Qualcomm (QCOM), Teva (TEVA), Expedia Inc. (EXPE), Comcast (CMCSA)
Analysts at Bernstein are out with a report this morning upgrading shares of Biogen Inc. (BIIB) with a ‘Outperform‘ from ‘Market Perform‘ rating. The firm however, lowered its price target for the... 
Tags BIIB News CMCSA
From Wall Street Pit
Market Update (NASDAQ:BIIB): Cramer — Be Careful Buying GrubHub, Biogen Is a Battleground
[at TheStreet] – Jim Cramer is not hungry for GrubHub and says Biogen is turning into a battle royale for biotech investors. Read more on this. Biogen Inc. (BIIB), with a current . . . → Read More:... 
Tags Healthcare NASDAQ:BIIB Markets
From Jutia Group
Market Update: Biogen Idec Inc (NASDAQ:BIIB) – SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen, Inc. – BIIB
[Accesswire] – NEW YORK, NY / ACCESSWIRE / July 24, 2015 / Pomerantz LLP is investigating claims on behalf of investors of Biogen (“Biogen” or the “Company”) (NASDAQ: BIIB). Such investors are advised... 
Tags Stock Markets NASDAQ:BIIB
From Jutia Group
Biogen Inc. (BIIB): Earnings Whisper
Biogen (BIIB) is set to announce its Q2/15 earnings results before the market open on Friday, July 23rd. Analysts expect the biotech company to report earnings per share of $4.10 and revenue of $2.71... 
Tags News Markets Latest
From Wall Street Pit
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X